We are live on ! Find out more
TEC

Tiger Eye Capital Portfolio holdings

AUM $113M
1-Year Est. Return 11.44%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
-11.44%
3 Year Est. Return
+116.39%
5 Year Est. Return
+328.27%
10 Year Est. Return
–
AUM
$480M
AUM Growth
+$68.6M
Cap. Flow
+$33.5M
Cap. Flow %
6.98%
Top 10 Hldgs %
68.76%
Holding
52
New
8
Increased
12
Reduced
11
Closed
6
Avg Time Held
5.3 quarters
Top 10 Avg Time Held
2.4 quarters
Top 20 Avg Time Held
2.6 quarters

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$17.6M
2
MA icon
Mastercard
MA
+$17M
3
ELV icon
Elevance Health
ELV
+$13.4M
4
AABA
Altaba Inc
AABA
+$11.1M
5
NFLX icon
Netflix
NFLX
+$8.4M

Sector Composition

Rank Sector Weight
1 Technology 35.68%
2 Communication Services 35.62%
3 Healthcare 8.12%
4 Consumer Discretionary 7.37%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NFLX icon
51
Netflix
NFLX
$290B
– –
-235,460
Closed -$8.4M –
AVLR
52
DELISTED
Avalara, Inc.
AVLR
– –
-40,745
Closed -$2.27M –

Similar funds

Tiger Eye Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Tiger Eye Capital held 52 positions worth $480M, up 17% from $412M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Tiger Eye Capital deployed $33.5M of net new capital in Q2 2019, opening 8 new positions and adding to 12 existing holdings. Its largest new stake was Upland Software: 41,068 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $17.6M trimmed.

  • Tiger Eye Capital's largest Q2 2019 buy was Upland Software: 41,068 shares worth $18.7M.
  • Tiger Eye Capital added most to GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2019, an estimated $15.7M increase.
  • Tiger Eye Capital's biggest Q2 2019 reduction was Thermo Fisher Scientific, cutting an estimated $17.6M.
  • Tiger Eye Capital fully exited Mastercard in Q2 2019, selling an estimated $17M.
  • Tiger Eye Capital's ten largest holdings make up 69% of its $480M portfolio in Q2 2019.
  • Tiger Eye Capital opened 8 new positions and closed 6 in Q2 2019.
  • Tiger Eye Capital's portfolio value rose 17% quarter-over-quarter to $480M.

Based on Tiger Eye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.